Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood–brain barrier function

The breakdown of the blood–brain barrier (BBB) has been considered to be a key step in the disease process of a number of neurological disorders such as cerebral ischemia and Alzheimer's disease. Many in vitro BBB models derived from animal tissues have been established to elucidate the mechanism of BBB insufficiency. However, only a few human immortalized in vitro BBB models have been reported. In the present study, a temperature‐sensitive SV40‐T antigen was introduced to immortalize cells using a retrovirus to obtain a better human in vitro BBB model which sustains physiological properties. This endothelial cell (EC) line, termed TY08, showed a spindle‐shaped morphology. The cells expressed all key tight junctional proteins, such as occludin, claudin‐5, zonula occludens (ZO)‐1 and ZO‐2 at their cell‐to‐cell boundaries, and had low permeability to inulin across its monolayer. The cells also expressed various influx and efflux transporters and exhibited the functional expression of p‐glycoprotein. Furthermore, the TY08 cells grew and proliferated well under the permissive temperature and stopped growing under the non‐permissive temperature to serve as physiological ECs forming the BBB. Thus, conditionally immortalized TY08 cells retaining the in vivo BBB functions should facilitate analyses for determining the pathophysiology of various neurological diseases. J. Cell. Physiol. 225: 519–528, 2010. © 2010 Wiley‐Liss, Inc.

[1]  J. Geiger,et al.  Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease , 2008, Journal of Neuroinflammation.

[2]  D. Stewart,et al.  Decreased junctional adhesion molecule-A expression during blood–brain barrier breakdown , 2008, Acta Neuropathologica.

[3]  T. Terasaki,et al.  A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters , 2007, Brain Research.

[4]  W. Haefeli,et al.  NKIM-6, a new immortalized human brain capillary endothelial cell line with conserved endothelial characteristics , 2007, Cell and Tissue Research.

[5]  T. Terasaki,et al.  Exogenous expression of claudin‐5 induces barrier properties in cultured rat brain capillary endothelial cells , 2007, Journal of cellular physiology.

[6]  J. Viña,et al.  Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. , 2006, American journal of physiology. Endocrinology and metabolism.

[7]  J. Southgate,et al.  PPARγ‐regulated tight junction development during human urothelial cytodifferentiation , 2006, Journal of cellular physiology.

[8]  C. Kirkpatrick,et al.  Retention of a differentiated endothelial phenotype by outgrowth endothelial cells isolated from human peripheral blood and expanded in long-term cultures , 2006, Cell and Tissue Research.

[9]  H. Gutmann,et al.  Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood–brain barrier , 2005, Brain Research.

[10]  A. Fagan,et al.  P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.

[11]  J. Greenwood,et al.  Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[13]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[14]  D. Keppler,et al.  Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain , 2004, Neuroscience.

[15]  R. Egleton,et al.  Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution , 2004, Brain Research.

[16]  R. Ransohoff,et al.  CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer , 2004, Journal of Neuroimmunology.

[17]  S. Cisternino,et al.  Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. , 2004, Cancer research.

[18]  J. Antel,et al.  Regulation of Cellular and Molecular Trafficking across Human Brain Endothelial Cells by Th1‐ and Th2‐Polarized Lymphocytes , 2004, Journal of neuropathology and experimental neurology.

[19]  W. Schaper,et al.  Simultaneous activation of several second messengers in hypoxia‐induced hyperpermeability of brain derived endothelial cells , 2004, Journal of cellular physiology.

[20]  C. Sibley,et al.  Characterization of cationic amino acid transporters and expression of endothelial nitric oxide synthase in human placental microvascular endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Emi Nakashima,et al.  New approaches to in vitro models of blood-brain barrier drug transport. , 2003, Drug discovery today.

[22]  R. Mansel,et al.  Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells , 2003, Journal of cellular physiology.

[23]  S. Tsukita,et al.  Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice , 2003, The Journal of cell biology.

[24]  H. Leese,et al.  Gene expression regulating epithelial intercellular junction biogenesis during human blastocyst development in vitro. , 2003, Molecular human reproduction.

[25]  Masahiko Watanabe,et al.  The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  M. L. Calonge,et al.  Human, rat and chicken small intestinal Na+‐Cl−‐creatine transporter: functional, molecular characterization and localization , 2002, The Journal of physiology.

[27]  S. McQuaid,et al.  Abnormal Endothelial Tight Junctions in Active Lesions and Normal‐appearing White Matter in Multiple Sclerosis , 2002, Brain pathology.

[28]  M. Obinata,et al.  mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a New in vitro BBB Model for Drug Targeting , 2000, Journal of drug targeting.

[29]  Eiji Takeda,et al.  Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)* , 1998, The Journal of Biological Chemistry.

[30]  R. Monette,et al.  Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood–brain barrier , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  L. Rubin,et al.  Occludin as a possible determinant of tight junction permeability in endothelial cells. , 1997, Journal of cell science.

[32]  G. Mealing,et al.  Angiotensin II‐induced fluid phase endocytosis in human cerebromicrovascular endothelial cells is regulated by the inositol‐phosphate signaling pathway , 1996, Journal of cellular physiology.

[33]  A. Schinkel,et al.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.

[34]  F. Joó Endothelial cells of the brain and other organ systems: Some similarities and differences , 1996, Progress in Neurobiology.

[35]  H. Yoshino,et al.  Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected] [published erratum appears in J Cell Biol 1994 Oct;127(1):265] , 1994, The Journal of cell biology.

[36]  H. Yoshino,et al.  Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected] [published erratum appears in J Cell Biol 1994 Oct;127(1):265] , 1994, The Journal of cell biology.

[37]  B. Swartz,et al.  The Human Brain GLUT1 Glucose Transporter: Ultrastructural Localization to the Blood—Brain Barrier Endothelia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  M. Itoh,et al.  Occludin: a novel integral membrane protein localizing at tight junctions , 1993, The Journal of cell biology.

[39]  P. Sharp,et al.  Cell lines established by a temperature-sensitive simian virus 40 large-T-antigen gene are growth restricted at the nonpermissive temperature , 1989, Molecular and cellular biology.

[40]  W. Pardridge The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[41]  I. Tamai,et al.  Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies , 2004, Pharmaceutical Research.

[42]  T. Terasaki,et al.  mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME). , 2002, Drug metabolism and pharmacokinetics.